In all, 65 breast cancer patients (10.6%) and 109 controls (10.1%) were heterozygous or homozygous carriers of the ADH1B*2 allele, corresponding to allele frequencies of 0.06 and 0.05, respectively. The gene discussed is ADH1B; the disease is breast carcinoma.